Woodiwiss Angela J, Norton Gavin R
Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa,
Curr Hypertens Rep. 2015 Apr;17(4):539. doi: 10.1007/s11906-015-0539-z.
The detection of left ventricular hypertrophy (LVH) is recommended for risk prediction, and changes in LV geometry may provide further prognostic information. Obesity is a major determinant of LVH, but the approach to LVH detection in obese hypertensives remains a challenge. In the present review, we discuss evidence leading to the recent acceptance of the use of LV mass indexed to height(2.7) or height(1.7) rather than body surface area, for LVH detection and its regression in obesity. We also review recent findings which indicate that obesity-induced LVH may be associated with concentric LV remodeling, and hence, that the presence of concentric LVH in obesity should not be assumed to indicate a cause of LVH other than obesity. We also discuss recent evidence for obesity and blood pressure producing additive and interactive effects on LV mass, and hence, that weight loss and blood pressure reduction are required to achieve appropriate regression.
推荐检测左心室肥厚(LVH)以进行风险预测,左心室几何形状的变化可能提供更多的预后信息。肥胖是LVH的主要决定因素,但在肥胖高血压患者中检测LVH的方法仍然是一项挑战。在本综述中,我们讨论了促使最近接受使用身高(2.7)或身高(1.7)指数化的左心室质量而非体表面积来检测LVH及其在肥胖中的逆转的证据。我们还回顾了最近的研究结果,这些结果表明肥胖诱导的LVH可能与左心室向心性重塑有关,因此,不应认为肥胖患者中存在向心性LVH就表明是除肥胖以外的LVH病因。我们还讨论了肥胖和血压对左心室质量产生相加和交互作用的最新证据,因此,需要减重和降低血压才能实现适当的逆转。